↓ Skip to main content

Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model

Overview of attention for article published in Antimicrobial Agents and Chemotherapy, May 2016

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model
Published in
Antimicrobial Agents and Chemotherapy, May 2016
DOI 10.1128/aac.00450-16
Pubmed ID
Authors
Abstract

Pre-Exposure Prophylaxis (PrEP), 1% tenofovir (TFV) vaginal gel has failed in clinical trials. To improve TFV efficacy in vaginal gel, we formulated tenofovir disoproxil fumarate (TDF) nanoparticles (NPs) in a thermosensitive (TMS) gel (TDF-NPs-TMS gel). TDF NPs were fabricated using Poly Lactic-co-Glycolic Acid (PLGA) polymer and an ion-pairing agent by oil-in-water emulsification. Efficacy of TDF-NPs-TMS gel was tested in humanized-bone marrow-liver-thymus (BLT) (hu-BLT) mice.Hu-BLT mice grouped as treatment (Rx; n=15) were administered TDF-NPs-TMS gel intravaginally having TDF at 0.1%, 0.5%, and 1% (w/v) concentration whereas control (Ctr; n=8) group received blank TMS gel. All Rx mice (0.1% (n=4), 0.5% (n=6) and 1% (n=5)) were vaginally challenged with two transmitted/founder (T/F) HIV-1 viruses (5x10(5)TCID50). Rx mice were challenged at 4 h (0.1%), 24 h (0.5%), and 7-days (1%) post-treatment (PT) and Ctr mice challenged at 4 h PT, respectively. Blood was drawn weekly for 4 weeks post-inoculation (PI) for plasma viral load (pVL) using qRT-PCR. Ctr mice had positive pVL within 2 weeks PI. Rx mice challenged at 4 h and 24 h showed 100% protection and no detectable pVL throughout the 4 weeks of follow-up (p=0.009; Mantel-Cox test). Mice challenged at 7 days were HIV-1 positive at 14 days PI. Further, HIV-1 viral RNA (vRNA) in vaginal and spleen tissues of Rx group mice with negative pVL were examined using in-situ hybridization (ISH) technique. vRNA was negative in all Rx mice studied.The present studies elucidate TDF-NPs-TMS gel as a long acting, coitus-independent HIV-1 vaginal protection modality.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Brazil 1 2%
Unknown 43 98%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 8 18%
Student > Master 8 18%
Student > Bachelor 5 11%
Researcher 4 9%
Student > Postgraduate 3 7%
Other 1 2%
Unknown 15 34%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 10 23%
Pharmacology, Toxicology and Pharmaceutical Science 5 11%
Biochemistry, Genetics and Molecular Biology 3 7%
Social Sciences 2 5%
Environmental Science 1 2%
Other 3 7%
Unknown 20 45%